In vitro and in vivo cytotoxic activity of native and ricin conjugated monoclonal antibodies to HBs antigen for Alexander primary liver cell carcinoma cells and tumours.
Open Access
- 1 June 1984
- Vol. 25 (6) , 619-623
- https://doi.org/10.1136/gut.25.6.619
Abstract
In in vitro and in vivo systems, native or ricin conjugated monoclonal anti-HBs, are capable of inhibiting or slowing the growth of Alexander primary hepatocellular carcinoma cells. Failure of the immune response to this component of the hepatitis B virus may be one permissive factor in the development of some primary liver cell carcinoma in chronic HBV carriers.Keywords
This publication has 12 references indexed in Scilit:
- Growth Characteristics of α-Foetoprotein-Secreting Human Hepatocellular Carcinoma in Athymic (Nude) MiceClinical Science, 1983
- A rapid one-step radiometric assay for hepatitis B surface antigen utilising monoclonal antibodiesJournal of Immunological Methods, 1982
- The Preparation and Cytotoxic Properties of Antibody‐Toxin ConjugatesImmunological Reviews, 1982
- DETECTION OF HEPATITIS B VIRUS DNA IN LIVER AND SERUM: A DIRECT APPRAISAL OF THE CHRONIC CARRIER STATEThe Lancet, 1981
- Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinomaNature, 1980
- Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell lineNature, 1980
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- HOST RESPONSES TO HEPATITIS-B INFECTION IN PATIENTS WITH PRIMARY HEPATIC CARCINOMA AND THEIR FAMILIESThe Lancet, 1976
- Mechanism of action of the toxic lectins abrin and ricinNature, 1974